Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7885)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2014 (publication date) through Dec 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yuan H, Li AJ, Ma SL, Cui LJ, Wu B, Yin L, Wu MC. Inhibition of autophagy significantly enhances combination therapy with sorafenib and HDAC inhibitors for human hepatoma cells. World J Gastroenterol 2014; 20(17): 4953-4962 [PMID: 24833845 DOI: 10.3748/wjg.v20.i17.4953] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i17/4953.htm |
| Number | Citing Articles |
| 1 |
Srimanta Patra, Prakash P. Praharaj, Daniel J. Klionsky, Sujit K. Bhutia. Vorinostat in autophagic cell death: A critical insight into autophagy-mediated, -associated and -dependent cell death for cancer prevention. Drug Discovery Today 2022; 27(1): 269 doi: 10.1016/j.drudis.2021.08.004
|
| 2 |
Michael J. Flynn, Anwar A. Sayed, Rohini Sharma, Abdul Siddique, David J. Pinato. Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma. Hepatology 2019; 69(5): 2258 doi: 10.1002/hep.30337
|
| 3 |
Jin-kun Xia, Xue-qian Qin, Lu Zhang, Shu-jun Liu, Xiao-lei Shi, Hao-zhen Ren. Roles and regulation of histone acetylation in hepatocellular carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.982222
|
| 4 |
Min Ju Lee, Jae-Sung Park, Seong Bin Jo, Young Ae Joe. Enhancing Anti-Cancer Therapy with Selective Autophagy Inhibitors by Targeting Protective Autophagy. Biomolecules & Therapeutics 2023; 31(1): 1 doi: 10.4062/biomolther.2022.153
|
| 5 |
Judith Knievel, Wolfgang Schulz, Annemarie Greife, Christiane Hader, Tobias Lübke, Ingo Schmitz, Peter Albers, Günter Niegisch. Multiple Mechanisms Mediate Resistance to Sorafenib in Urothelial Cancer. International Journal of Molecular Sciences 2014; 15(11): 20500 doi: 10.3390/ijms151120500
|
| 6 |
Mireia Casasampere, Yadira F. Ordóñez, Josefina Casas, Gemma Fabrias. Dihydroceramide desaturase inhibitors induce autophagy via dihydroceramide-dependent and independent mechanisms. Biochimica et Biophysica Acta (BBA) - General Subjects 2017; 1861(2): 264 doi: 10.1016/j.bbagen.2016.11.033
|
| 7 |
Zhonghao Jiang, Chaoliu Dai. Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib. Journal of Hepatocellular Carcinoma 2023; : 257 doi: 10.2147/JHC.S396231
|
| 8 |
Ahmed Mostafa Ibrahim Abdelrahman Hassan, Yuxin Zhao, Xiuping Chen, Chengwei He. Blockage of Autophagy for Cancer Therapy: A Comprehensive Review. International Journal of Molecular Sciences 2024; 25(13): 7459 doi: 10.3390/ijms25137459
|
| 9 |
María A. Rodríguez-Hernández, Patricia de la Cruz-Ojeda, Paloma Gallego, Elena Navarro-Villarán, Pavla Staňková, José A. Del Campo, Otto Kučera, Moustafa Elkalaf, Tumisang E. Maseko, Zuzana Červinková, Jordi Muntané. Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells. Biochemical Pharmacology 2020; 176: 113902 doi: 10.1016/j.bcp.2020.113902
|
| 10 |
John Chen, Hui‑Yen Chuang, Yi‑Jen Liao, Fei‑Ting Hsu, Yen‑Chung Chen, Wei‑Hsun Wang, Jeng‑Jong Hwang. Enhanced cytotoxicity of human hepatocellular carcinoma cells following pretreatment with sorafenib combined with trichostatin A. Oncology Letters 2018; doi: 10.3892/ol.2018.9582
|
| 11 |
Meng Niu, Duo Hong, Teng-Chuang Ma, Xiao-Wei Chen, Jin-Hang Han, Jun Sun, Ke Xu. Short-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinoma. Medicine 2016; 95(49): e5591 doi: 10.1097/MD.0000000000005591
|
| 12 |
Nestor Prieto-Domínguez, Raquel Ordóñez, Anna Fernández, Andres García-Palomo, Jordi Muntané, Javier González-Gallego, José L. Mauriz. Modulation of Autophagy by Sorafenib: Effects on Treatment Response. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00151
|
| 13 |
Weiwei Tang, Ziyi Chen, Wenling Zhang, Ye Cheng, Betty Zhang, Fan Wu, Qian Wang, Shouju Wang, Dawei Rong, F. P. Reiter, E. N. De Toni, Xuehao Wang. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-0187-x
|
| 14 |
Kaku Goto, Dorcas A. Annan, Tomoko Morita, Wenwen Li, Ryosuke Muroyama, Yasuo Matsubara, Sayaka Ito, Ryo Nakagawa, Yasushi Tanoue, Masahisa Jinushi, Naoya Kato. Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study. Scientific Reports 2016; 6(1) doi: 10.1038/srep38407
|
| 15 |
Areerat Kunanopparat, Ingorn Kimkong, Tanapat Palaga, Pisit Tangkijvanich, Boonchoo Sirichindakul, Nattiya Hirankarn. Increased ATG5-ATG12 in hepatitis B virus-associated hepatocellular carcinoma and their role in apoptosis. World Journal of Gastroenterology 2016; 22(37): 8361-8374 doi: 10.3748/wjg.v22.i37.8361
|
| 16 |
Kim Freese, Tatjana Seitz, Peter Dietrich, Serene M.L. Lee, Wolfgang E. Thasler, Anja Bosserhoff, Claus Hellerbrand. Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro. Cancers 2019; 11(10): 1587 doi: 10.3390/cancers11101587
|
| 17 |
Yang‑Ling Li, Ming‑Jun Rao, Ning‑Yu Zhang, Lin‑Wen Wu, Neng‑Ming Lin, Chong Zhang. BAY 87‑2243 sensitizes hepatocellular carcinoma Hep3B cells to histone deacetylase inhibitors treatment via GSK‑3β activation. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7500
|
| 18 |
Hala Shalhoub, Patrick Gonzalez, Alexandre Dos Santos, Julie Guillermet-Guibert, Nicolas Moniaux, Nicolas Dupont, Jamila Faivre. Simultaneous activation and blockade of autophagy to fight hepatocellular carcinoma. Autophagy Reports 2024; 3(1) doi: 10.1080/27694127.2024.2326241
|
| 19 |
Diamantis I. Tsilimigras, Ioannis Ntanasis-Stathopoulos, Demetrios Moris, Eleftherios Spartalis, Timothy M. Pawlik. Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective. Surgical Oncology 2018; 27(4): 611 doi: 10.1016/j.suronc.2018.07.015
|
| 20 |
Ahmed M. Elshazly, Jingwen Xu, Nebras Melhem, Alsayed Abdulnaby, Aya A. Elzahed, Tareq Saleh, David A. Gewirtz. Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?. Cancers 2024; 16(17): 2989 doi: 10.3390/cancers16172989
|
| 21 |
Elena G. Varlamova, Venera V. Khabatova, Sergey V. Gudkov, Egor A. Turovsky. Ca2+-Dependent Effects of the Selenium-Sorafenib Nanocomplex on Glioblastoma Cells and Astrocytes of the Cerebral Cortex: Anticancer Agent and Cytoprotector. International Journal of Molecular Sciences 2023; 24(3): 2411 doi: 10.3390/ijms24032411
|
| 22 |
Lian Liu, Jia-Zhi Liao, Xing-Xing He, Pei-Yuan Li. The role of autophagy in hepatocellular carcinoma: friend or foe. Oncotarget 2017; 8(34): 57707 doi: 10.18632/oncotarget.17202
|
| 23 |
Thuy T.P. Nguyen, Phuc L. Nguyen, So-Hyun Park, Chang Hwa Jung, Tae-Il Jeon. Hydrogen Sulfide and Liver Health: Insights into Liver Diseases. Antioxidants & Redox Signaling 2024; 40(1-3): 122 doi: 10.1089/ars.2023.0404
|
| 24 |
Ganlu Deng, Shan Zeng, Yanling Qu, Qingqing Luo, Cao Guo, Ling Yin, Ying Han, Yiyi Li, Changjing Cai, Yaojie Fu, Hong Shen. BMP4 promotes hepatocellular carcinoma proliferation by autophagy activation through JNK1-mediated Bcl-2 phosphorylation. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0828-x
|
| 25 |
Ying Yuan, Daifeng Li, Xiang Hu, Yizhou Li, Wanrong Yi, Pengcheng Li, Yong Zhao, Zonghuan Li, Aiming Yu, Chao Jian, Aixi Yu. Chidamide augment sorafenib-derived anti-tumor activities in human osteosarcoma cells lines and xenograft mouse model. Medical Oncology 2022; 39(6) doi: 10.1007/s12032-022-01684-1
|
| 26 |
Yafei Wu, Jigang Zhang, Qin Li. Autophagy, an accomplice or antagonist of drug resistance in HCC?. Cell Death & Disease 2021; 12(3) doi: 10.1038/s41419-021-03553-7
|
| 27 |
Ting Liu, Jing Zhang, Kangdi Li, Lingnan Deng, Hongxiang Wang. Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00408
|
| 28 |
Francesca Angeletti, Gianluca Fossati, Alessandra Pattarozzi, Roberto Würth, Agnese Solari, Antonio Daga, Irene Masiello, Federica Barbieri, Tullio Florio, Sergio Comincini. Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells. Frontiers in Molecular Neuroscience 2016; 9 doi: 10.3389/fnmol.2016.00107
|
| 29 |
Li Lu, Ke Li, Yun-Hua Mao, Hu Qu, Bing Yao, Wen-Wen Zhong, Bo Ma, Zhong-Yang Wang. Gold-chrysophanol nanoparticles suppress human prostate cancer progression through inactivating AKT expression and inducing apoptosis and ROS generation in vitro and in vivo. International Journal of Oncology 2017; 51(4): 1089 doi: 10.3892/ijo.2017.4095
|
| 30 |
Sanja Aveic, Gian Paolo Tonini. Resistance to receptor tyrosine kinase inhibitors in solid tumors: can we improve the cancer fighting strategy by blocking autophagy?. Cancer Cell International 2016; 16(1) doi: 10.1186/s12935-016-0341-2
|
| 31 |
Malina Xiao, Alice Benoit, Meriem Hasmim, Caroline Duhem, Guillaume Vogin, Guy Berchem, Muhammad Zaeem Noman, Bassam Janji. Targeting Cytoprotective Autophagy to Enhance Anticancer Therapies. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.626309
|
| 32 |
Xinyu Li, Yong Zhou, Yongshuang Li, Liang Yang, Yingbo Ma, Xueqiang Peng, Shuo Yang, Jingang Liu, Hangyu Li. Autophagy: A novel mechanism of chemoresistance in cancers. Biomedicine & Pharmacotherapy 2019; 119: 109415 doi: 10.1016/j.biopha.2019.109415
|
| 33 |
Ammad Farooqi, Sundas Fayyaz, Ming-Feng Hou, Kun-Tzu Li, Jen-Yang Tang, Hsueh-Wei Chang. Reactive Oxygen Species and Autophagy Modulation in Non-Marine Drugs and Marine Drugs. Marine Drugs 2014; 12(11): 5408 doi: 10.3390/md12115408
|
| 34 |
YONGSHUN CHEN, XIAOHONG LI, LEIMING GUO, XIAOYUAN WU, CHUNYU HE, SONG ZHANG, YANJING XIAO, YUANYUAN YANG, DAXUAN HAO. Combining radiation with autophagy inhibition enhances suppression of tumor growth and angiogenesis in esophageal cancer. Molecular Medicine Reports 2015; 12(2): 1645 doi: 10.3892/mmr.2015.3623
|
| 35 |
Jun Ma, Li Weng, Yiping Jia, Bingyan Liu, Shaoqiu Wu, Lei Xue, Xiang Yin, Aiwu Mao, Zhongmin Wang, Mingyi Shang. PTBP3 promotes malignancy and hypoxia‐induced chemoresistance in pancreatic cancer cells by ATG12 up‐regulation. Journal of Cellular and Molecular Medicine 2020; 24(5): 2917 doi: 10.1111/jcmm.14896
|
| 36 |
Farnaz Ahmadi‐Dehlaghi, Parisa Mohammadi, Elahe Valipour, Pouya Pournaghi, Sarah Kiani, Kamran Mansouri. Autophagy: A challengeable paradox in cancer treatment. Cancer Medicine 2023; 12(10): 11542 doi: 10.1002/cam4.5577
|
| 37 |
Guanghan Fan, Xuyong Wei, Xiao Xu. Is the era of sorafenib over? A review of the literature. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920927602
|
| 38 |
Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, Vasiliki E. Georgakopoulou, Panagiotis Sarantis, Efstathios A. Antoniou, Michalis V. Karamouzis, Afroditi Nonni, Dimitrios Schizas, Evangelos Diamantis, Evangelos Koustas, Paraskevi Farmaki, Athanasios Syllaios, Alexandros Patsouras, Konstantinos Kontzoglou, Nikolaos Trakas, Dimitrios Dimitroulis. Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities. Journal of Personalized Medicine 2021; 11(3): 223 doi: 10.3390/jpm11030223
|
| 39 |
Paul Peixoto, Céline Grandvallet, Jean-Paul Feugeas, Michaël Guittaut, Eric Hervouet. Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes. Cells 2019; 8(12): 1656 doi: 10.3390/cells8121656
|
| 40 |
Thi Ha Nguyen, Tuan Minh Nguyen, Dinh Thi Minh Ngoc, Taesik You, Mi Kyung Park, Chang Hoon Lee. Unraveling the Janus-Faced Role of Autophagy in Hepatocellular Carcinoma: Implications for Therapeutic Interventions. International Journal of Molecular Sciences 2023; 24(22): 16255 doi: 10.3390/ijms242216255
|
| 41 |
Qiang Yu, Jiajun Ding, Shisen Li, Yunlong Li. Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions. Cancer Letters 2024; 590: 216856 doi: 10.1016/j.canlet.2024.216856
|
| 42 |
Samaneh Siapoush, Ramazan Rezaei, Helia Alavifard, Behzad Hatami, Mohammad Reza Zali, Massoud Vosough, Shahrokh Lorzadeh, Marek J. Łos, Kaveh Baghaei, Saeid Ghavami. Therapeutic implications of targeting autophagy and TGF-β crosstalk for the treatment of liver fibrosis. Life Sciences 2023; 329: 121894 doi: 10.1016/j.lfs.2023.121894
|
| 43 |
Laurence Booth, Andrew Poklepovic, Paul Dent. Neratinib decreases pro-survival responses of [sorafenib + vorinostat] in pancreatic cancer. Biochemical Pharmacology 2020; 178: 114067 doi: 10.1016/j.bcp.2020.114067
|
| 44 |
Eunbyul Ji, Chongtae Kim, Hoin Kang, Sojin Ahn, Myeongwoo Jung, Youlim Hong, Hyosun Tak, Sukchan Lee, Wook Kim, Eun Kyung Lee. RNA Binding Protein HuR Promotes Autophagosome Formation by Regulating Expression of Autophagy-Related Proteins 5, 12, and 16 in Human Hepatocellular Carcinoma Cells. Molecular and Cellular Biology 2019; 39(6) doi: 10.1128/MCB.00508-18
|
| 45 |
Tatiana V. Denisenko, Inna N. Budkevich, Boris Zhivotovsky. Cell death-based treatment of lung adenocarcinoma. Cell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0063-y
|
| 46 |
Jiafa He, Li Deng, Heping Liu, Taiying Chen, Shengying Chen, Shangzhou Xia, Yubin Liu. BCL2L10/BECN1 modulates hepatoma cells autophagy by regulating PI3K/AKT signaling pathway. Aging 2019; 11(2): 350 doi: 10.18632/aging.101737
|
| 47 |
WANXIN PENG, TONG DU, ZIHAO ZHANG, FENGYI DU, JIE JIN, AIHUA GONG. Knockdown of autophagy-related gene LC3 enhances the sensitivity of HepG2 cells to epirubicin. Experimental and Therapeutic Medicine 2015; 9(4): 1271 doi: 10.3892/etm.2015.2266
|
| 48 |
Jing Liu, Guangming Li, Xiang Wang, Liang Wang, Rui Zhao, Juanxia Wang, Yin Kong, Jie Ding, Juan Li, Lingyi Zhang. Droxinostat, a Histone Deacetylase Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cell Lines via Activation of the Mitochondrial Pathway and Downregulation of FLIP. Translational Oncology 2016; 9(1): 70 doi: 10.1016/j.tranon.2016.01.004
|
| 49 |
Anup S. Pathania, Ubaid S. Makhdoomi, Fayaz A. Malik. Genome Analysis and Human Health. 2017; : 1 doi: 10.1007/978-981-10-4298-0_1
|
| 50 |
K Ashokachakkaravarthy, Biju Pottakkat. Sorafenib resistance and autophagy in hepatocellular carcinoma: A concealed threat. Journal of Cancer Research and Practice 2019; 6(3): 107 doi: 10.4103/JCRP.JCRP_6_19
|
| 51 |
Xiaoyu Yan, Rui Tian, Jicheng Sun, Yuanxin Zhao, Buhan Liu, Jing Su, Minghua Li, Wei Sun, Xuesong Xu. Sorafenib-Induced Autophagy Promotes Glycolysis by Upregulating the p62/HDAC6/HSP90 Axis in Hepatocellular Carcinoma Cells. Frontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.788667
|
| 52 |
Tohada M. AL-Noshokaty, Noha M. Mesbah, Dina M. Abo-Elmatty, Ahmed I. Abulsoud, Asmaa R. Abdel-Hamed. Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis. Life Sciences 2022; 303: 120675 doi: 10.1016/j.lfs.2022.120675
|
| 53 |
Yingying Li, Shan Gao, Xiyou Du, Jianbo Ji, Yanwei Xi, Guangxi Zhai. Advances in autophagy as a target in the treatment of tumours. Journal of Drug Targeting 2022; 30(2): 166 doi: 10.1080/1061186X.2021.1961792
|